Largest biotech companies by total assets
Everything the company owns, as its balance sheet stood at the end of the latest fiscal year.
Amgen leads the 24 biotech companies ranked by total assets, at TRY 4.57T, ahead of Gilead Sciences (TRY 2.98T) and Biogen (TRY 1.48T). Figures as of 18 Nov 2026, 18:07 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 24
- First
- AmgenTRY 4.57T
- Median
- TRY 128.9B
- Combined market value
- TRY 42.49T
- Countries
- 5
Market values as of .
All countries▾
All sectors▾
Biotech▾
| # | Company | Total assets ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | AmgenAMGN · Health Care | TRY 4.57T | TRY 12.2T | TRY 22,547.09 | 2.38% down | 34% up | ||
| 2 | Gilead SciencesGILD · Health Care | TRY 2.98T | TRY 10.61T | TRY 8,554.52 | 0.38% down | 33% up | ||
| 3 | BiogenBIIB · Health Care | TRY 1.48T | TRY 1.88T | TRY 12,727.12 | 0.62% up | 49% up | ||
| 4 | BioNTechBNTX · Health Care | TRY 1.23T | TRY 1.05T | TRY 4,240.19 | 0.93% down | 16% down | ||
| 5 | ModernaMRNA · Health Care | TRY 622.3B | TRY 4.12T | TRY 10,185.13 | 2.35% down | 755% up | ||
| 6 | argenxARGX · Health Care | TRY 437.9B | TRY 3T | TRY 47,671.48 | 0.25% down | 4% up | ||
| 7 | QiagenQGEN · Health Care | TRY 316.8B | TRY 517.6B | TRY 2,506.69 | 0.10% down | 12% up | ||
| 8 | Neurocrine BiosciencesNBIX · Health Care | TRY 233.6B | TRY 832.5B | TRY 8,224.92 | 1.71% down | 20% up | ||
| 9 | VaxcytePCVX · Health Care | TRY 151.4B | TRY 468.9B | TRY 2,962.13 | 1.13% down | 22% up | ||
| 10 | RepligenRGEN · Health Care | TRY 148.8B | TRY 560.5B | TRY 8,768.87 | 7.20% up | 5% up | ||
| 11 | ExelixisEXEL · Health Care | TRY 143.5B | TRY 851.4B | TRY 3,489.19 | 0.99% up | 63% up | ||
| 12 | Bio-TechneTECH · Health Care | TRY 130.5B | TRY 576.8B | TRY 3,671.91 | 0.24% up | 26% up | ||
| 13 | Halozyme TherapeuticsHALO · Health Care | TRY 127.4B | TRY 555.1B | TRY 4,869.13 | 0.59% up | 37% up | ||
| 14 | Revolution MedicinesRVMD · Health Care | TRY 118.8B | TRY 1.74T | TRY 8,037.54 | 2.05% down | 131% up | ||
| 15 | CRISPR TherapeuticsCRSP · Health Care | TRY 114.3B | TRY 206.2B | TRY 2,125.89 | 4.98% up | 21% down | ||
| 16 | Kymera TherapeuticsKYMR · Health Care | TRY 87.9B | TRY 527B | TRY 6,172.91 | 0.72% up | 87% up | ||
| 17 | Krystal BiotechKRYS · Health Care | TRY 67.3B | TRY 467.2B | TRY 15,765.16 | 4.70% up | 46% up | ||
| 18 | ImmunovantIMVT · Health Care | TRY 48.3B | TRY 349.5B | TRY 1,688.61 | 0.81% up | 43% up | ||
| 19 | CG OncologyCGON · Health Care | TRY 39.9B | TRY 367.3B | TRY 4,112.58 | 3.29% up | 85% up | ||
| 20 | Twist BioscienceTWST · Health Care | TRY 32.4B | TRY 405.3B | TRY 5,944.94 | 5.24% up | 340% up | ||
| 21 | Adaptive BiotechnologiesADPT · Health Care | TRY 25.9B | TRY 233.9B | TRY 1,444.73 | 0.54% up | 88% up | ||
| 22 | ImmunityBioIBRX · Health Care | TRY 25.3B | TRY 360.6B | TRY 338.93 | 7.35% up | 193% up | ||
| 23 | Scholar Rock HoldingSRRK · Health Care | TRY 20.4B | TRY 291.7B | TRY 2,391.19 | 5.17% up | 14% up | ||
| 24 | Kodiak SciencesKOD · Health Care | TRY 17.7B | TRY 319.5B | TRY 4,885.77 | 0.07% up | 396% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 50.4364 TRY).
Questions and answers
Which biotech companies rank first by total assets?
Amgen (TRY 4.57T), Gilead Sciences (TRY 2.98T) and Biogen (TRY 1.48T) are the top three of the 24 biotech companies ranked by total assets as of 18 Nov 2026, 18:07 UTC.
How many biotech companies are in this ranking?
24 are ranked by total assets.
What are these biotech companies worth together?
The 24 biotech companies ranked by total assets have a combined market value of TRY 42.49T as of 18 Nov 2026, 18:07 UTC.
What does ranking by total assets measure?
Everything the company owns, as its balance sheet stood at the end of the latest fiscal year.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest biotech companies by total assets”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=total-assets
Underlying data: Yahoo Finance; SEC EDGAR.